Malignant Solid Tumors Clinical Trials

31 clinical trials for Malignant Solid Tumors across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid Tumors — RECRUITING · PHASE1
• Characterization of Hyperpolarized Pyruvate MRI Reproducibility — RECRUITING · NA
• Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors — RECRUITING
• Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia — RECRUITING · PHASE2
• A Study of TAK-505 in Adults With Solid Tumors — RECRUITING · PHASE1
• A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors — RECRUITING · PHASE2
• A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors — RECRUITING · PHASE2
• A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• An Open-label, Rollover Study of Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib Study — RECRUITING · PHASE3
• The Effect of Serum Ferritin in irAE — RECRUITING · NA
• Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors — RECRUITING · PHASE1
• Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research — RECRUITING
• First-in-human, open-label, dose-escalation trial with expansion cohorts to evaluate safety of GEN1047 in subjects with malignant solid tumors — OTHER · PHASE2
• One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting — NOT_YET_RECRUITING · PHASE3
• First-in-Human, Open-Label, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety and Preliminary Efficacy of GEN1078 in Subjects With Malignant Solid Tumors — OTHER · PHASE2
• First-In-Human, Open-Label, Dose Escalation Trial with Expansion Cohorts to Evaluate the Safety and Preliminary Efficacy of GEN1055 as Monotherapy and as Combination Therapy in Subjects with Malignant Solid Tumors. — OTHER · PHASE2
• Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors — COMPLETED · PHASE1
• First in Human Study of 68Ga/64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors — COMPLETED · PHASE1
• An Observational Study, Called ROCURS, to Learn About COVID-19 Related Outcomes in People With Cancer Who Are Treated With Tyrosine Kinase Inhibitors (TKIs) Including Regorafenib or Sorafenib — COMPLETED
• A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients — OTHER · PHASE1
• A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors — OTHER · PHASE1
• Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors — OTHER · PHASE1
• AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas — COMPLETED · PHASE1
• Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors — COMPLETED · PHASE1
• tTF-NGR Phase I Study — COMPLETED · PHASE1
• Cancer Vaccine Targeting Brachyury Protein in Tumors — COMPLETED · PHASE1
• PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy — COMPLETED · PHASE4
• Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors — COMPLETED · PHASE1
• Clinical Safety and Preliminary Efficacy of MAGE-A4 TCR Gene-Modified T Cells to Treat Malignant Tumors — OTHER · PHASE1
• Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan — COMPLETED · PHASE1

Refine this search